US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 21.170
  • -0.360-1.67%
Close Apr 24 16:00 ET
  • 21.210
  • +0.040+0.19%
Post 16:35 ET
2.03BMarket Cap-3905P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Development of genome editing-based therapies36.28M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States36.28M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Gene Editing
Gene Editing
Intraday-1.01%